240 related articles for article (PubMed ID: 34957164)
21. HBOC-201 vasoactivity in a phase III clinical trial in orthopedic surgery subjects--extrapolation of potential risk for acute trauma trials.
Freilich D; Pearce LB; Pitman A; Greenburg G; Berzins M; Bebris L; Ahlers S; McCarron R
J Trauma; 2009 Feb; 66(2):365-76. PubMed ID: 19204509
[TBL] [Abstract][Full Text] [Related]
22. Crosslinked, polymerized, and PEG-conjugated hemoglobin-based oxygen carriers: clinical safety and efficacy of recent and current products.
Jahr JS; Akha AS; Holtby RJ
Curr Drug Discov Technol; 2012 Sep; 9(3):158-65. PubMed ID: 21745179
[TBL] [Abstract][Full Text] [Related]
23. The reduction of the allogenic transfusion requirement in aortic surgery with a hemoglobin-based solution.
LaMuraglia GM; O'Hara PJ; Baker WH; Naslund TC; Norris EJ; Li J; Vandermeersch E
J Vasc Surg; 2000 Feb; 31(2):299-308. PubMed ID: 10664499
[TBL] [Abstract][Full Text] [Related]
24. A new oxygen transport agent.
Standl T
Haematologica; 2005 Apr; 90(4):437-8. PubMed ID: 15820934
[TBL] [Abstract][Full Text] [Related]
25. Hematologic effects of a novel hemoglobin-based oxygen carrier in normal male and female subjects.
Hughes GS; Francome SF; Antal EJ; Adams WJ; Locker PK; Yancey EP; Jacobs EE
J Lab Clin Med; 1995 Nov; 126(5):444-51. PubMed ID: 7595029
[TBL] [Abstract][Full Text] [Related]
26. Measuring circulating blood volume using infused hemoglobin-based oxygen carrier (oxyglobin) as an indicator: verification in a canine hypovolemia model.
Jahr JS; Lurie F; Bezdikian V; Driessen B; Gunther RA
Am J Ther; 2008; 15(2):98-101. PubMed ID: 18356627
[TBL] [Abstract][Full Text] [Related]
27. Hemoglobin-Based Oxygen Carrier (HBOC) Development in Trauma: Previous Regulatory Challenges, Lessons Learned, and a Path Forward.
Keipert PE
Adv Exp Med Biol; 2017; 977():343-350. PubMed ID: 28685464
[TBL] [Abstract][Full Text] [Related]
28. Hemoglobin-based oxygen carrier preserves submaximal exercise capacity in humans.
Hughes GS; Yancey EP; Albrecht R; Locker PK; Francom SF; Orringer EP; Antal EJ; Jacobs EE
Clin Pharmacol Ther; 1995 Oct; 58(4):434-43. PubMed ID: 7586936
[TBL] [Abstract][Full Text] [Related]
29. Low-volume resuscitation with a polymerized bovine hemoglobin-based oxygen-carrying solution (HBOC-201) provides adequate tissue oxygenation for survival in a porcine model of controlled hemorrhage.
York GB; Eggers JS; Smith DL; Jenkins DH; McNeil JD; Mueller D; Josephs JD; Kerby JD
J Trauma; 2003 Nov; 55(5):873-85. PubMed ID: 14608160
[TBL] [Abstract][Full Text] [Related]
30. [Preoperative hemodilution with bovine hemoglobin. Acute hemodynamic effects in liver surgery patients ].
Standl T; Wilhelm S; Horn EP; Burmeister M; Gundlach M; Schulte am Esch J
Anaesthesist; 1997 Sep; 46(9):763-70. PubMed ID: 9412256
[TBL] [Abstract][Full Text] [Related]
31. Elevated troponin I level with hemoglobin based oxygen carrying solutions (HBOCs) as a priming solution despite improved left ventricular function.
Neragi-Miandoab S; Vlahakes GJ
Interact Cardiovasc Thorac Surg; 2006 Apr; 5(2):135-8. PubMed ID: 17670534
[TBL] [Abstract][Full Text] [Related]
32. Bovine polymerized hemoglobin (hemoglobin-based oxygen carrier-201) resuscitation in three swine models of hemorrhagic shock with militarily relevant delayed evacuation--effects on histopathology and organ function.
Johnson T; Arnaud F; Dong F; Philbin N; Rice J; Asher L; Arrisueno M; Warndorf M; Gurney J; McGwin G; Kaplan L; Flournoy WS; Apple FS; Pearce LB; Ahlers S; McCarron R; Freilich D
Crit Care Med; 2006 May; 34(5):1464-74. PubMed ID: 16540964
[TBL] [Abstract][Full Text] [Related]
33. Hypotensive resuscitation using a polymerized bovine hemoglobin-based oxygen-carrying solution (HBOC-201) leads to reversal of anaerobic metabolism.
McNeil CJ; Smith LD; Jenkins LD; York MG; Josephs MJ
J Trauma; 2001 Jun; 50(6):1063-75. PubMed ID: 11426122
[TBL] [Abstract][Full Text] [Related]
34. Prolonged low-volume resuscitation with HBOC-201 in a large-animal survival model of controlled hemorrhage.
Fitzpatrick CM; Biggs KL; Atkins BZ; Quance-Fitch FJ; Dixon PS; Savage SA; Jenkins DH; Kerby JD
J Trauma; 2005 Aug; 59(2):273-81; discussion 281-3. PubMed ID: 16294065
[TBL] [Abstract][Full Text] [Related]
35. Users Guide to Pitfalls and Lessons Learned About HBOC-201 During Clinical Trials, Expanded Access, and Clinical Use in 1,701 Patients.
Mackenzie CF; Dubé GP; Pitman A; Zafirelis M
Shock; 2019 Oct; 52(1S Suppl 1):92-99. PubMed ID: 29076972
[TBL] [Abstract][Full Text] [Related]
36. Effects of hemodilution with a hemoglobin-based oxygen carrier (HBOC-201) on ischemia/reperfusion injury in a model of partial warm liver ischemia of the rat.
Zapletal C; Bode A; Lorenz MW; Gebhard MM; Golling M
Microvasc Res; 2009 Dec; 78(3):386-92. PubMed ID: 19715706
[TBL] [Abstract][Full Text] [Related]
37. Resuscitation from hemorrhagic shock comparing standard hemoglobin-based oxygen carrier (HBOC)-201 versus 7.5% hypertonic HBOC-201.
Rivera-Chavez FA; Huerta S; Brown R; York GB; Minei JP
J Trauma; 2007 Nov; 63(5):1113-9. PubMed ID: 17993959
[TBL] [Abstract][Full Text] [Related]
38. The pharmacology of tissue oxygenation by biopure's hemoglobin-based oxygen carrier, Hemopure (HBOC-201).
Pearce LB; Gawryl MS
Adv Exp Med Biol; 2003; 530():261-70. PubMed ID: 14562723
[TBL] [Abstract][Full Text] [Related]
39. Prevention of the pulmonary vasoconstrictor effects of HBOC-201 in awake lambs by continuously breathing nitric oxide.
Yu B; Volpato GP; Chang K; Bloch KD; Zapol WM
Anesthesiology; 2009 Jan; 110(1):113-22. PubMed ID: 19104178
[TBL] [Abstract][Full Text] [Related]
40. Enhanced central organ oxygenation after application of bovine cell-free hemoglobin HBOC-201.
Freitag M; Standl TG; Gottschalk A; Burmeister MA; Rempf C; Horn EP; Strate T; Schulte Am Esch J
Can J Anaesth; 2005 Nov; 52(9):904-14. PubMed ID: 16251554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
